Surgical resection followed by entire hemithorax irradiation in patients with stage IVa thymoma

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035540

Enrollment

Unknown

Registered

2020-08-13

Start date

2020-04-01

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thymoma

Interventions

1:macroscopically complete resection plus entire hemithorax irradiation

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Primary stage IVa (pleural dissemination) thymoma; 2. Pleural recurrence after primary mediastinal tumor resection, and radiation to tumor bed <= 50Gy; 3. Aged between 18-75 years; 4. Tolerable of surgery.

Exclusion criteria

Exclusion criteria: 1. Large amount of pleural effusion; 2. Active lung inflammation; 3. With myasthenia gravis, not controlled with medical therapy; 4. Other thoracic malignancy history; 5. Received immune therapy (like anti PD-1 or PD-L1); 6. Received chemotherapy containing bleomycin.

Design outcomes

Primary

Measure	Time frame
progression free survival;	—

Secondary

Measure	Time frame
toxicity;overall survival;	—

Countries

China

Contacts

Public ContactChanglu Wang

Shanghai Chest Hospital

2452183417@qq.com+86 18017321629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026